Cargando…
Impact of Peak Systolic Velocity Ratio after Drug-Coated Balloon for Femoropopliteal Disease: Three-Month Serial Observation Vessel Echo Study
Aim: No flow-limiting dissection after drug-coated balloon (DCB) treatment for femoropopliteal (FP) lesions is considered as one of the endpoints, but it has not investigated the difference between each vessel dissection. This study aimed to clarify whether there is a difference between no dissectio...
Autores principales: | Kawasaki, Daizo, Nakata, Aya, Nishian, Kunihiko, Nishimura, Machiko, Fujiwara, Reiko, Nakata, Tsuyoshi, Fukunaga, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444800/ https://www.ncbi.nlm.nih.gov/pubmed/34588389 http://dx.doi.org/10.5551/jat.63197 |
Ejemplares similares
-
Clinical Effects of Planned Endovascular Therapy for Critical Limb Ischemia Patients with Tissue Loss
por: Fukunaga, Masashi, et al.
Publicado: (2019) -
Vessel Patency and Associated Factors of Drug‐Coated Balloon for Femoropopliteal Lesion
por: Soga, Yoshimitsu, et al.
Publicado: (2022) -
Peak systolic velocity ratio derived from quantitative vessel analysis for restenosis after femoropopliteal intervention: a multidisciplinary review from Endovascular Asia
por: Kawarada, Osami, et al.
Publicado: (2019) -
Mortality risk of femoropopliteal paclitaxel-coated devices remains inconclusive
por: Takahara, Mitsuyoshi, et al.
Publicado: (2019) -
Association of Smoking, Diabetes, and Dialysis with the Presence of Popliteal Lesions in Femoropopliteal Artery Disease
por: Takahara, Mitsuyoshi, et al.
Publicado: (2023)